Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy
dc.creator | Iturriaga-Vásquez P. | |
dc.creator | Alzate-Morales J. | |
dc.creator | Bermudez I. | |
dc.creator | Varas R. | |
dc.creator | Reyes-Parada M. | |
dc.date.accessioned | 2020-09-02T22:20:40Z | |
dc.date.accessioned | 2022-11-08T20:19:11Z | |
dc.date.available | 2020-09-02T22:20:40Z | |
dc.date.available | 2022-11-08T20:19:11Z | |
dc.date.created | 2020-09-02T22:20:40Z | |
dc.date.issued | 2015 | |
dc.identifier | 101, , 9-17 | |
dc.identifier | 10436618 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4960 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143060 | |
dc.language | en | |
dc.publisher | Academic Press | |
dc.subject | Allosteric ligands | |
dc.subject | Drug design | |
dc.subject | Medicinal chemistry | |
dc.subject | Nicotinic receptor | |
dc.subject | Orthosteric ligands | |
dc.subject | Polypharmacology | |
dc.subject | 1,1 dimethyl 4 phenylpiperazinium | |
dc.subject | 1,2,3,5 tetrahydro 5 methyl 1 (3 pyridylcarbamoyl)pyrrolo[2,3 f]indole | |
dc.subject | 3 (2 azetidinylmethoxy)pyridine | |
dc.subject | amfebutamone | |
dc.subject | carbamazepine | |
dc.subject | chlorpheniramine | |
dc.subject | epibatidine | |
dc.subject | galantamine | |
dc.subject | ligand gated ion channel | |
dc.subject | lobeline | |
dc.subject | mepyramine | |
dc.subject | neurotransmitter | |
dc.subject | nicotinic receptor | |
dc.subject | rivanicline | |
dc.subject | varenicline | |
dc.subject | ligand | |
dc.subject | nicotinic agent | |
dc.subject | nicotinic receptor | |
dc.subject | allosterism | |
dc.subject | Alzheimer disease | |
dc.subject | binding site | |
dc.subject | central nervous system | |
dc.subject | depression | |
dc.subject | drug design | |
dc.subject | epilepsy | |
dc.subject | human | |
dc.subject | neuromodulation | |
dc.subject | neurotransmitter release | |
dc.subject | nonhuman | |
dc.subject | polypharmacology | |
dc.subject | priority journal | |
dc.subject | protein assembly | |
dc.subject | protein binding | |
dc.subject | protein expression | |
dc.subject | protein family | |
dc.subject | receptor binding | |
dc.subject | receptor upregulation | |
dc.subject | Review | |
dc.subject | tobacco dependence | |
dc.subject | animal | |
dc.subject | binding site | |
dc.subject | brain | |
dc.subject | chemical structure | |
dc.subject | chemistry | |
dc.subject | drug effects | |
dc.subject | metabolism | |
dc.subject | nerve cell | |
dc.subject | polypharmacology | |
dc.subject | Allosteric Regulation | |
dc.subject | Animals | |
dc.subject | Binding Sites | |
dc.subject | Brain | |
dc.subject | Humans | |
dc.subject | Ligands | |
dc.subject | Models, Molecular | |
dc.subject | Neurons | |
dc.subject | Nicotinic Agonists | |
dc.subject | Polypharmacology | |
dc.subject | Receptors, Nicotinic | |
dc.title | Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy | |
dc.type | Review |